Earnings per share for the last twelve months: Genprex Inc. (GNPX)
Genprex, Inc. (GNPX) possesses significant market influence due to the ONCOPREX system, which delivers tumor suppressor genes into tumors. Laboratory automation via robotic screening accelerates preclinical development. GURU.Markets analytics show a change in the rolling annual EPS, where -159.06 represents the latest level value. Stable demand for oncology therapies positions the asset beyond economic cycles, tying success to FDA verdicts.
Analytical breakdowns and data insights for company Genprex Inc. (GNPX)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt obligations and liquidity statistics:
- net income and valuation multiples indicators:
GNPX - Company Net Income|Future Profit Genprex, Inc.|GNPX - Price to Earnings Multiple|Projected Price to Earnings Genprex|GNPX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Genprex, Inc.|GNPX - Operating income before deduction of amortization|Earnings per share for the last twelve months Genprex|GNPX - Earnings per share for the last 12 months|Quarterly EPS earnings growth genprex.com|GNPX - Net earnings per share growth this year|Expected earnings per share growth for next year Genprex, Inc.
- revenue and sales proceeds data:
Fundamental valuation:GNPX - Genprex, Inc.
Trailing twelve months (TTM) earnings per share reflects the portion of profit attributable to a single common share. Investors utilize this indicator to assess real capital generation efficiency and business growth rates. By analyzing the rolling annual earnings per share, one can determine the stability of the issuer's margins. For Genprex, Inc. (GNPX), this metric is critical, as the development of the ONCOPREX system requires colossal expenditures. Positive dynamics would confirm the commercial success of the lung cancer therapy.
Key competitors
ONC: Net earnings per share for the last 12 months|HALO - Net earnings per share (EPS TTM)|Revolution Medicines, Inc. (RVMD) - Earnings per share for the last twelve months|Ascentage Pharma Group International - Earnings per share for the trailing year|CGON (CG Oncology Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months UroGen Pharma Corp URGN|Net earnings per share (EPS TTM) BCAX|personalis.com (PSNL) - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) ERAS (Erasca)|Delcath Systems Inc (DCTH) - Net earnings per one share for the last twelve months|YMAB - Earnings per share for the last twelve months|AURA (Aura Corp) - Earnings per share for the last 12 months|candeltx.com (CADL) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ARAY (accuray.com)|Earnings per share for the last twelve months SELLAS Life Sciences Group, Inc.|ACTU: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CTOR|HURA - Net earnings per one share for the last twelve months|Protara Therapeutics - Net earnings per share for the last 12 months|FATE: Earnings per share for the last 12 months|WHWK: Net earnings per share for the last 12 months|Earnings per share for the trailing year TCRX (TScan Therapeutics)|CSBR: Net earnings per share (EPS TTM)|XBIT - Net earnings per share for the last four quarters|Earnings per share for the last twelve months CEL-SCI Corp.|Earnings per share for the last 12 months OSTX (ostherapies.com)|Net earnings per share (EPS TTM) RADX|Net earnings per share for the last 12 months artivabio.com ARTV|Adlai Nortye - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Veru Corporation (VERU)|Tempest Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Xilio Therapeutics, Inc. (XLO)|renovarobio.com (RENB) - Earnings per share for the last twelve months|Earnings per share for the last 12 months MURA|Earnings per share for the last twelve months Kairos Pharma Limited|OnKure - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months GDTC (CytoMed Therapeutics)|curis.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) APLM (Apollomics)|THAR - Net earnings per share for the last 12 months|Advanced Biomed Corp - Net earnings per share (EPS TTM)|CLDI - Net earnings per share (EPS TTM)|Sunshine Biopharma, Inc. (SBFM) - Earnings per share for the last twelve months|Earnings per share for the last 12 months XBIO|SLRX (Salarius Pharmaceuticals, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Purple Biotech Ltd (PPBT)|Net earnings per share (EPS TTM) AONC|BGNE - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Checkpoint Therapeutics CKPT|Earnings per share for the trailing year ELEV|ICAD: Net earnings per share for the last 12 months|Earnings per share for the trailing year IKNA (Ikena Oncology, Inc.)|NTBL: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Viracta Therapeutics, Inc.|Net earnings per share for the last 12 months MOR|Net earnings per share (EPS TTM) nayabiosciences.com|Earnings per share for the last twelve months Ascentage Pharma (AAPGV)
